Jump to Content
Jump to Main Navigation
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Show Items
SECTION I. Magnitude/Significance of Drug-Induced Diseases: Impact on the Healthcare System
Show Items
SECTION II. Drug-Induced Dermatologic Diseases
Show Items
SECTION III. Drug-Induced Neurological Diseases
Show Items
SECTION IV. Drug-Induced Psychiatric Diseases
Chapter 18:
Depression
Chapter 19:
Anxiety
Chapter 20:
Psychosis
SECTION V. Drug-Induced Pulmonary Diseases
Show Items
SECTION VI. Drug-Induced Cardiovascular Diseases
Show Items
SECTION VII. Drug-Induced Endocrine Diseases
Show Items
SECTION VIII. Drug-Induced Gastrointestinal Diseases
Show Items
SECTION IX. Drug-Induced Diseases of the Kidney and Fluid & Electrolyte Disorders
Show Items
SECTION X. Drug-Induced Hematological Disorders
Show Items
SECTION XI. Drug-Induced Bone, Joint, and Muscle Diseases
Show Items
SECTION XII. Miscellaneous Drug-Induced Diseases
Show Items
Chapter 20:
Psychosis
in
Drug-Induced Diseases
Author:
Jessica L. Gören
DOI:
https://doi.org/10.37573/9781585285310.020
Restricted access
PDF Preview
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585285310/ch020.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
[3.236.207.90]
3.236.207.90
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
